Primary testicular lymphoma

Journal of the National Medical Association

Volumn 99, Issue 11, 2007, Pages 1277-1282

  Vural, Filiz ^a   Cagirgan, Seckin ^a   Saydam, Guray ^a   Hekimgil, Mine ^a   Soyer, Nur Akad ^a   Tombuloglu, Murat ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Testicular lymphoma; Treatment outcomes

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; MESNA; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE DURATION; HUMAN; HUMAN TISSUE; NONHODGKIN LYMPHOMA; ORCHIECTOMY; PRIORITY JOURNAL; REMISSION; TESTIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORCHIECTOMY; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; TURKEY; VINCRISTINE;

EID: 37049020684     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sasai K, Yamabe H, Tsutsui K, et al. Primary testicular non-Hodgkin's lymphoma: a clinical study and review of the literature. Am J Clin Oncol. 1997; 20:59-62.
2. Zucca E, Conconi A, Mughal TI, et al; International Extranodal Lymphoma Study Group. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003; 21:20-27.
3. Shahab N, Doll DC. Testicular lymphoma. Semin Oncol. 1999; 26:259-269.
4. Moller MB, d'Amore F, Christensen BE. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer. 1994; 30A:1760-1764.
5. Darby S, Hancock BW. Localised non-Hodgkin lymphoma of the testis: the Sheffield Lymphoma Group experience. Int J Oncol. 2005; 26:1093-1099.
6. Hasselblom S, Ridell B, Wedel H, et al. Testicular lymphoma, a retrospective, population-based, clinical and immunohistochemical study. Acta Oncol. 2004; 43:758-765.
7. Zietman AL, Coen JJ, Ferry JA, et al. The management and outcome of stage IAE nonHodgkin's lymphoma of the testis. J Urol. 1996; 155:943-946.
8. Tondini C, Ferreri AJ, Siracusano L, et al. Diffuse large-cell lymphoma of the testis. J Clin Oncol. 1999; 17:2854-2858.
9. Liang R, Chiu E, Loke SL. An analysis of 12 cases of non-Hodgkin's lymphomas involving the testis. Ann Oncol. 1990; 1:383.
10. Pectasides D, Economopoulos T, Kouvatseas G, et al. Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience. Oncology. 2000; 58:286-292.
11. Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer. 2000; 88:154-161.
12. Crellin AM, Hudson BV, Bennett MH, et al. Non-Hodgkin's lymphoma. of the testis. Radiother Oncol. 1993; 27:99-106.
13. Martenson JA Jr, Buskirk SJ, Ilstrup DM, et al. Patterns of failure in primary non-Hodgkin's lymphoma. J Clin Oncol. 1988; 6:297-302.
14. Duncan PR, Checa F, Gowing NF, McElwain TJ. Extranodal non-Hodgkin's lymphoma presenting in the testicle: a clinical and pathological study of 24 cases. Cancer. 1980; 45:1578-1584.
15. Baldetorp LA, Brunkvall J, Cavallin-Stahl E, et al. Malignant lymphoma of the testis. Br J Urol. 1984; 56:525-530.
16. Van der Maazen RW, Noordijk EM, Thomas J, et al. Combined modality treatment is the treatment of choice for stage I/IE intermediate and high grade non-Hodgkin's lymphomas. Radiother Oncol. 1998; 49:1-7.
17. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971; 31:1860-1861.
18. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggresive non-Hodgkin's Lymphoma. N Engl J Med. 1993; 329:987-994.
19. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November, 1997 Hematol J. 2000;1:53-62
20. Thomas DA, Faderl S, O'Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006; 106(7):1569-80
21. Hill QA, Owen RG. CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev. 2006;20(6):319-32
22. Visco C, Medeiros LJ, Mesina OM, et al. Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based chemotherapy? Clin Lymphoma. 2001;2:40-46
23. Seymour JF, Solomon B, Wolf MM, et al. Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. Clin Lymphoma. 2001; 2:109-115.
24. Lagrange JL, Ramaioli A, Theodore CH, et al. Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol. 2001; 12:1313-1319.
25. Aviles A, Neri N, Huerta-Guzman J, et al. Testicular lymphoma: organ-specific treatment did not improve outcome. Oncology. 2004; 67:211-214.
26. Ciatto S, Cionini L. Malignant lymphoma of the testis. Acta Radiol Oncol Radiat Phys Biol. 1979; 18:572-576.
27. Buskirk SJ, Evans RG, Banks PM, et al. Primary lymphoma of the testis. Int J Radiat Oncol Biol Phys. 1982; 8:1699-1703.
28. Read G. Lymphomas of the testis-results of treatment 1960-77. Clin Radiol. 1981; 32:687-692.
29. Turner RR, Colby TV, Macintosh FR. Testicular lymphomas: a clinico-pathologic study of 35 cases. Cancer. 1981; 48:2095-2102.
30. Gospodarowicz MK, Sutcliffe SB. The Extranodal Lymphomas. Semin Radiat Oncol. 1995; 5:281-300.
31. Touroutoglou N, Dimopoulos MA, Younes A, et al. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol. 1995; 13:1361-1367.
32. Connors JM, Klimo P, Voss N, et al. Testicular lymphoma: improved outcome with early brief chemotherapy. J Clin Oncol. 1988; 6:776-781.■